[Strategic dominance of the mucosal immune system in the defence and tolerance]
- PMID: 22132615
[Strategic dominance of the mucosal immune system in the defence and tolerance]
Abstract
Mucosal immune system is functionally characterized by its ability to limit the access of environmental antigens such as food, airborne materials, and commensal microbes to the systemic immune compartment, leading to reduction in the magnitude of systemic immune responses. Mucosal immune system reacts at the site of antigen exposure and at anatomically distant mucosal sites by specific antibodies production and specific cellular immunity. The mucosal administration of neoantigen induces specific mucosal and systemic antibodies production and systemic effector T cells anergy accompanied by induction of regulatory T cells, phenomenon termed mucosal tolerance. Based on above observations, several studies test the ability to prevent some autoimmune diseases by mucosal administration of respective antigens but with little to no success. This review attempts to describe mechanisms involved in the induction of immune response and tolerance after immunization by mucosal routes - oral or intranasal administration. Further it aims to elucidate conditions critical for elicitation of mucosal tolerance.
Similar articles
-
Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.Immunol Lett. 2004 May 15;93(2-3):97-108. doi: 10.1016/j.imlet.2004.02.005. Immunol Lett. 2004. PMID: 15158604 Review.
-
The postnatal development of the mucosal immune system and mucosal tolerance in domestic animals.Vet Res. 2006 May-Jun;37(3):443-53. doi: 10.1051/vetres:2006013. Epub 2006 Apr 14. Vet Res. 2006. PMID: 16611557 Review.
-
Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans.Behring Inst Mitt. 1997 Feb;(98):33-43. Behring Inst Mitt. 1997. PMID: 9382757 Review.
-
Immune response versus mucosal tolerance to mucosally administered antigens.Vaccine. 2005 Mar 7;23(15):1800-3. doi: 10.1016/j.vaccine.2004.11.009. Vaccine. 2005. PMID: 15734045 Review.
-
[Inducing tolerance against antigens through initial contact via the mucous membrane].Ned Tijdschr Geneeskd. 2002 Dec 14;146(50):2406-9. Ned Tijdschr Geneeskd. 2002. PMID: 12518517 Review. Dutch.